SecBot SecBot

DCTH

DELCATH SYSTEMS, INC.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0000872912 Healthcare & Medical Devices
$19.87 −0.68 (−3.31%)
Nov 16 4:00 PM ET · prev $20.55
Market cap
$743.8M
Small cap
Consensus
Buy
92% Buy or better · 12 analysts
Median target
$27.00
+36% · range $25.00–36.00
1 year
+130.8%
from $8.61 · Nov 17
30 days
+38.3%
from $14.37
52-week range
$8.19–21.77
−9% from high · low Nov 20
Avg volume 20D
781.9K
Nov 9 spike 3.45M
Short interest
1.78M
≈5.1% of shares · −5.7%
Days to cover
5.7
at average volume
Insider net
−$338.2K
2 buyers · 1 seller · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
12
analyzed by SecBot
SecBot read BULLISH 5 reports · 90 days
Balance 0 bearish · 1 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 3/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders bought $150.3K at an average $8.98. 1 insider sold $488.5K. Price is 121% above their cost.

  • InstitutionsBULLISH

    Q3 2026: 20 added (0 new), 8 trimmed or exited.

  • AnalystsBULLISH

    11 of 12 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.207 → −$0.077 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest −5.7% to 1.78M shares. 5.7 days to cover, ≈5.1% of shares.

  • TrendUPTREND

    25% above its 50-day average. New closing high $21.77 on Nov 11.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 9.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.ADD3,996,569$63.8M
MORGAN STANLEYADD550,557$8.8M
MARSHALL WACE, LLPADD371,893$5.9M
VANGUARD PORTFOLIO MANAGEMENT LLCADD335,171$5.4M
DIMENSIONAL FUND ADVISORS LPADD314,903$5.0M
JPMORGAN CHASE & CODOUBLED150,424$2.4M
BARCLAYS PLCADD147,166$2.4M
CIBC WORLD MARKET INC.TRIM111,982$1.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts
Buy 92% rate it Buy or better
Strong Buy3Buy8Hold1Sell0Strong Sell0
12-month targets · 5 analysts

Price is below the lowest target. Median implies +36%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 12, 2026BTIG
REITERATE
REITERATEBuy
Nov 10, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Nov 9, 2026BTIG
MAINTAIN
MAINTAINBuy
Aug 7, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Aug 6, 2026BTIG
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$150.3K
bought · 2 insiders
$488.5K
sold · 1 insider
+121.2%
vs their $8.98 cost
DateInsiderTypeValue
Nov 12, 2026
Martell Bridget A
Director
Nov 12, 2026
SELL$43.0K
Nov 12, 2026
Martell Bridget A
Director
Nov 12, 2026
EXERCISE$176.6K
Nov 12, 2026
Martell Bridget A
Director
Nov 12, 2026
SELL$445.5K
Oct 13, 2026
Rosalind Advisors, Inc.
Director
Oct 13, 2026
CONVERT3,627 sh
Oct 13, 2026
Rosalind Advisors, Inc.
Director
Oct 13, 2026
OTHER27,502 sh
Oct 13, 2026
Rosalind Advisors, Inc.
Director
Oct 13, 2026
CONVERT36.27 sh
May 13, 2026
CZEREPAK ELIZABETH
Director
May 13, 2026
AWARD22,500 sh
May 13, 2026
SALAMON STEVEN A J
Director
May 13, 2026
AWARD22,500 sh

Earnings setup

Estimates
−$0.08
EPS estimate, this quarter
+63%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.08-$0.13–-$0.04-10.7%$25.8M
Next Q-$0.01-$0.05–$0.02-200.0%$31.1M
Current FY$0.18$0.13–$0.21+233.3%$116.5M
Next FY$0.27$0.12–$0.51+505.6%$139.9M

Washington

Corporate Lobbying

4 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
1,775,571
shares short
-5.7%
vs prior settlement
5.7
days to cover
≈5.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Daniel Kaufman filed an amended Schedule 13G disclosing a reduced passive stake of 2.9% (1,016,524 shares) in Delcath…
SC 13G/A · Impact 3/10
Nov 12, 2026 Insider
Martell Bridget A sold 1,930 shares
Director @ $22.26 ($43.0K)
Nov 12, 2026 Insider
Martell Bridget A acquired via exercise 22,500 shares
Director @ $7.85 ($176.6K)
Nov 12, 2026 Insider
Martell Bridget A sold 20,570 shares
Director @ $21.66 ($445.5K)
Nov 9, 2026 SEC
Delcath Systems reported Q3 2026 revenue of $35.1M (vs. $25.8M consensus) and GAAP EPS of $0.17 (vs. $-0.08…
8-K · Impact 6/10
Nov 9, 2026 Earnings result
DCTH Q3 2026 Earnings: EPS $0.17 (+300.0% vs est)
Nov 4, 2026 SEC
Three institutional asset managers increased their DCTH positions in Q3 2026, adding a net $2.7M in holdings. The…
INST-CLUSTER · Impact 3/10
Sep 30, 2026 Inst.
BlackRock, Inc. · ADD
3,996,569 shares ($63.8M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent

SecBot reports

12 filings · 4 bullish · 0 bearish · 1 mixed · 7 neutral
All DCTH filing & press-release reports (12)